NUVATION BIO INC innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	WIPO (World Intellectual Property Organization)	18
#2	United States	10
#3	EPO (European Patent Office)	6
#4	Australia	5
#5	Canada	4
#6	Republic of Korea	4
#7	Singapore	4
#8	Brazil	3
#9	Israel	3

#	Industry
#1	Pharmaceuticals
#2	Organic fine chemistry

#	Technology
#1	Heterocyclic compounds
#2	Therapeutic chemical compounds
#3	Medical preparations
#4	Steroids
#5	Organic chemistry methods

Publication	Filing date	Title
WO2021030620A1	2020-08-13	Heterocyclic compounds as kinase inhibitors
WO2021030623A1	2020-08-13	Heterocyclic compounds as kinase inhibitors
US2021002293A1	2020-07-01	Heterocyclic compounds as bet inhibitors
WO2021003314A1	2020-07-01	Heterocyclic compounds as kinase inhibitors
US2020360523A1	2020-05-13	Anti-cancer nuclear hormone receptor-targeting compounds
WO2020210381A1	2020-04-08	Heterocyclic compounds and uses thereof
WO2020210375A1	2020-04-08	Heterocyclic compounds and uses thereof
WO2020210377A1	2020-04-08	Heterocyclic compounds and uses thereof
WO2020210380A1	2020-04-08	Heterocyclic compounds and uses thereof
WO2020210383A1	2020-04-08	Heterocyclic compounds and uses thereof
WO2020150674A1	2020-01-17	Heterocyclic compounds as adenosine antagonists
WO2020150675A1	2020-01-17	Compounds and uses thereof
WO2020150677A1	2020-01-17	Heterocyclic compounds as adenosine antagonists
US2020231589A1	2020-01-17	1,8-naphthyridinone compounds and uses thereof
WO2020113088A1	2019-11-27	Diarylhydantoin compounds and methods of use thereof
WO2020113094A1	2019-11-27	Pyrrole and pyrazole compounds and methods of use thereof
US2020140459A1	2019-10-30	Heterocyclic compounds as bet inhibitors
KR20210018291A	2019-05-14	Anticancer nuclear hormone receptor-targeting compounds
BR112020015431A2	2019-02-15	HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS
EP3694509A1	2018-10-09	Heterocyclic compounds and uses thereof